These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5535003)

  • 1. A new test for myasthenia gravis: recording of miniature end-plate potentials in situ.
    Lovelace RE; Stone R; Zablow L
    Neurology; 1970 Apr; 20(4):385. PubMed ID: 5535003
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnosis and management of myasthenia gravis.
    Walsh JC
    Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia in frogs immunized against cholinergic-receptor protein.
    Nastuk WL; Niemi WD; Alexander JT; Chang HW; Nastuk MA
    Am J Physiol; 1979 Jan; 236(1):C53-7. PubMed ID: 219703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of end plate potentials (EPP) and miniature end plate potentials (MEPP) by means of the Linc-8-computer, demonstrated with in vitro recordings from intercostal muscle of a patient with myasthenia gravis].
    Kruckenberg P; Bauer H
    Pflugers Arch; 1969; 307(2):R106. PubMed ID: 5814753
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiologic and pharmacologic studies on the calcium-effective state in myasthenia gravis].
    Takamori M; Takaoka Y
    Shinkei Kenkyu No Shimpo; 1970; 14(3):515-25. PubMed ID: 5531602
    [No Abstract]   [Full Text] [Related]  

  • 6. Incrementing responses in myasthenia gravis.
    Mayer RF; Williams IR
    Arch Neurol; 1974 Jul; 31(1):24-6. PubMed ID: 4365402
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental myasthenia due to alpha-bungarotoxin.
    Takamori M; Iwanaga S
    Neurology; 1976 Sep; 26(9):844-8. PubMed ID: 181695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavioral of evoked potentials in repeated stimulation of the facial nerve and electromyographic diagnosis of myasthenia gravis].
    Bassi S; Crespi V; Passerini D; Smirne S
    Riv Neurol; 1975; 45(1):60-3. PubMed ID: 167419
    [No Abstract]   [Full Text] [Related]  

  • 9. The neuromuscular junction with special reference to myasthenia gravis.
    Hubbard JI
    Proc Aust Assoc Neurol; 1965; 3():55-60. PubMed ID: 5881782
    [No Abstract]   [Full Text] [Related]  

  • 10. Some different aspects of post-tetanic phenomena in myasthenia gravis.
    Pinelli P; Arrigo A; Mille T
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):190. PubMed ID: 4166736
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis as a receptor disorder.
    Drachman DB; Kao I; Pestronk A; Toyka KV
    Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenic syndrome studied with single fiber electromyography.
    Schwartz MS; Stålberg E
    Arch Neurol; 1975 Dec; 32(12):815-7. PubMed ID: 173269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous end-plate activity in normal subjects and in patients with myasthenia gravis.
    Grob D
    Ann N Y Acad Sci; 1971 Sep; 183():248-69. PubMed ID: 5287826
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuromuscular junction. Part II: myasthenia gravis.
    Brumback RA
    Am Fam Physician; 1981 Feb; 23(2):126-33. PubMed ID: 7457320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "End-plate noise" in electromyography.
    Wiederholt WC
    Neurology; 1970 Mar; 20(3):214-24. PubMed ID: 5461051
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of antibodies against skeletal muscle constituents on muscle function in rats.
    Namba T; Grob D
    Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982
    [No Abstract]   [Full Text] [Related]  

  • 19. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis.
    Kim YI; Sanders DB
    Exp Neurol; 1981 Jul; 73(1):1-19. PubMed ID: 6265267
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR; Kim YI; Sanders DB
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.